Wright Medical Technology has announced an addition of $90 million to the $240 million settlement amount for the Wright hip litigation for the plaintiffs injured by the metal-on-metal hip implant products. Most of the cases were centralized four years ago in the U.S. District Court, Northern District of Georgia. The amount was added in order to…
What Happened In The MassTorts World Last Month? 2017-Sep
The JPML is reviewing the motion filed with them to transfer and consolidate the "National Prescription Opiate Litigation" which was long due to handling the Opioid crisis sweeping across the nation. Opiate drug makers are also facing lawsuits by cities, counties, and states. The US Department of Justice in every state has also taken up…
What Happened In The MassTorts World Last Month? 2017-Aug
The very first bellwether trial for TRT lawsuits ended in a mistrial which involved a plaintiff whose allegation against AndroGel was that it caused his heart attack, thereby bringing a pause phase. But the $150 Million verdict to be paid as punitive damage by AbbVie…
What Happened In The MassTorts World Last Month? 2017-Jul
Another ruling went in favor of the defendant, drug manufacturer Pfizer, for its antidepressant drug Zoloft by a panel of the 3rd U.S. Circuit Court of Appeals in Philadelphia, when they ruled to uphold the April 2016 dismissal of 300 Zoloft cases on the grounds that the testimony given by the Plaintiff's…
Newsletter - December 2015
Litigating an action such as the one involving Xarelto requires myriad factors to be in place. Neural IT has a great track record of producing quality work in both the Mass Tort & Personal Injury arenas.
In an instance such as a Xarelto litigation, Neural IT's highly trained medical doctors look through a patient's medical and…
Newsletter - October 2015
How much is too much? Sometimes, too much business is a very good problem to have. What about information and data that is so vast that it becomes cumbersome for your business to function properly, and it feels like an anchor is pulling your business down? When dealing with larger datasets, organizations face difficulties in being able to…
Newsletter - September 2015
Diabetes is a widespread problem throughout the country. In fact, it's so prevalent that it's now commonplace. This is why various pharmaceuticals are quick to find a cure drug or, at the very least, a "band-aid" solution to this ever-growing problem. Which is why the Japanese pharmaceutical Takeda released Actos, a drug used to treat Type-2…
Newsletter - June 2015
Whenever a drug comes on the market to enhance the lives of its consumers, the drug, more probable than not, does anything but. One such example is Lipitor. Known by its technical moniker Atorvastatin, was marketed and used to lower cholesterol. However, not long after the FDA issued a warning that this statin has been linked to memory loss and…
Newsletter - May 2015
The drug Zofran (Ondansetron) was manufactured to help cancer patients to treat nausea that usually follows chemotherapy treatments. The FDA's approval of Zofran was limited to only this use. However, manufacturer GlaxoSmithKline took the liberty of marketing the drug to pregnant women to treat morning sickness. Unfortunately, not only did the…
Newsletter - April 2015
The drug Zofran (Ondansetron) was manufactured to help cancer patients to treat nausea that usually follows chemotherapy treatments. The FDA's approval of Zofran was limited to only this use. However, manufacturer GlaxoSmithKline took the liberty of marketing the drug to pregnant women to treat morning sickness. Unfortunately, not only did the…
Newsletter - January 2015
Boston Scientific Corp. (henceforth "Defendant"), a developer & manufacturer of medical devices, in November 2014, was ordered to pay four women over $26 million after a Miami federal court jury found that it was liable for marketing faulty Transvaginal mesh devices.